Trial intelligence / Profile preview

Sertraline for prevention of complex regional pain syndrome after distal radius fracture

IRCT20250623066231N1Phase 3Completed

Sponsor
Mashhad University of Medical Sciences
Start
Oct 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, single-blind trial of sertraline in complex regional pain syndrome (CRPS) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Sudomotor signs, Pain intensity and 1 more. Started Oct 2025; status: completed.

02

Drugs

sertraline
03

Conditions

complex regional pain syndrome (CRPS)

Beyond the preview

Go deeper on IRCT20250623066231N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250623066231N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call